Catalyst Wire Dossier Catalyst Wire Dossier

CU-10101 Unguent

· Cutia Therapeutics (Wuxi) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CU-10101 Unguent, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Trial to Evaluate CU-10101 Unguent [Phase 1]

See pricing